BCIQ Profiles

Company Profile Report

Bertilimumab: Preliminary Ph II data

Preliminary data from 3 patients with moderate to extensive bullous pemphigoid in an open-label, U.S. and Israeli Phase II trial showed that 10 mg/kg

Read the full 247 word article

How to gain access

Continue reading with a
two-week free trial.